Preclinical In Vivo Imaging
Non-Invasive Imaging for Systemic Tumor Models
Using preclinical in vivo imaging along with Champions' cutting-edge oncology research platforms, researchers are able to evaluate disease progression using systemic tumor models.
Using bioluminescence imaging (BLI) through IVIS® offers the ability to non-invasively measure qualitatively and quantitatively the tumor burden within each animal in real-time throughout your in-life study.
Champions has optimized several luciferase-tagged tumor models within the preclinical in vivo imaging platform that can be used to detect and monitor tumor growth in real-time, in order to evaluate therapeutic efficacy.
HL-60 (Coming Soon)
MV4-11 (Coming Soon)
NALM6 (Coming Soon)
BW51473.3 (Coming Soon)
Available Metastatic Tumor Models:
- B16-F10 (Coming Soon)
Available Orthotopic Tumor Models:
- MM1.R (Coming Soon)